These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8157792)

  • 1. Is pentoxifylline the drug of the decade?
    Ely H
    J Am Acad Dermatol; 1994 Apr; 30(4):639-42. PubMed ID: 8157792
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentoxifylline use in dermatology.
    Çakmak SK; Çakmak A; Gönül M; Kiliç A; Gül Ü
    Inflamm Allergy Drug Targets; 2012 Dec; 11(6):422-32. PubMed ID: 22680624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephropathy in type 2 diabetes.
    Mora C; Garcia J; Navarro JF
    N Engl J Med; 2000 Feb; 342(6):441; author reply 442. PubMed ID: 10681230
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecule of the month. Ruboxistaurin mesilate hydrate.
    Drug News Perspect; 2003 Dec; 16(10):691. PubMed ID: 14747848
    [No Abstract]   [Full Text] [Related]  

  • 5. Ruboxistaurin.
    Taulien CA; Joy SV
    Drugs Today (Barc); 2006 Sep; 42(9):577-85. PubMed ID: 17028667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of PKC in the pathogenesis of diabetic vascular complications].
    Inoguchi T; Umeda F
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():67-72. PubMed ID: 12430209
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy.
    Navarro JF; Mora C
    Diabetes Care; 1999 Jun; 22(6):1006-8. PubMed ID: 10372263
    [No Abstract]   [Full Text] [Related]  

  • 8. Aldose reductase inhibitors and diabetic complications.
    Raskin P; Rosenstock J
    Am J Med; 1987 Aug; 83(2):298-306. PubMed ID: 3113248
    [No Abstract]   [Full Text] [Related]  

  • 9. Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats.
    DiPetrillo K; Gesek FA
    Am J Nephrol; 2004; 24(3):352-9. PubMed ID: 15205554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
    Hotta N; Sakamoto N
    Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
    [No Abstract]   [Full Text] [Related]  

  • 11. New hope for ending complications. Working together to protect your body from diabetes damage.
    Gebel E
    Diabetes Forecast; 2012 Apr; 65(4):56, 59-60. PubMed ID: 22582527
    [No Abstract]   [Full Text] [Related]  

  • 12. Pentoxifylline for Diabetic Nephropathy: an Important Opportunity to Re-purpose an Old Drug?
    Bhanot S; Leehey DJ
    Curr Hypertens Rep; 2016 Jan; 18(1):8. PubMed ID: 26747265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of pentoxifylline on the ocular rheographic pulse in diabetic patients].
    Colombati S; Monti L; Baggiani M; Filippini F
    Ric Clin Lab; 1989; 19 Suppl 1():185-7. PubMed ID: 2629085
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
    Ferrari E; Fioravanti M; Patti AL; Viola C; Solerte SB
    Pharmatherapeutica; 1987; 5(1):26-39. PubMed ID: 3602021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline and diabetic neuropathy.
    Sainati SM
    Diabetes Care; 1991 Oct; 14(10):930. PubMed ID: 1812883
    [No Abstract]   [Full Text] [Related]  

  • 16. Pentoxifylline and diabetic neuropathy.
    Cohen KL; Harris S
    Ann Intern Med; 1987 Oct; 107(4):600-1. PubMed ID: 3631805
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of modulation of vascular endothelial growth factor and tumor necrosis factor-alpha in gastric ulcer healing in diabetic rats.
    Baraka AM; Guemei A; Gawad HA
    Biochem Pharmacol; 2010 Jun; 79(11):1634-9. PubMed ID: 20144589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline for diabetic kidney disease.
    Shan D; Wu HM; Yuan QY; Li J; Zhou RL; Liu GJ
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006800. PubMed ID: 22336824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to prevent the microvascular complications of type 2 diabetes beyond glucose control.
    Valencia WM; Florez H
    BMJ; 2017 Jan; 356():i6505. PubMed ID: 28096078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy.
    Navarro-González JF; Jarque A; Muros M; Mora C; García J
    Cytokine Growth Factor Rev; 2009 Apr; 20(2):165-73. PubMed ID: 19251467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.